Kilitch Drugs Limited Stock Short Ratio
KILITCH Stock | 323.95 9.00 2.86% |
Kilitch Drugs Limited fundamentals help investors to digest information that contributes to Kilitch Drugs' financial success or failures. It also enables traders to predict the movement of Kilitch Stock. The fundamental analysis module provides a way to measure Kilitch Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kilitch Drugs stock.
Kilitch | Short Ratio |
Kilitch Drugs Limited Company Short Ratio Analysis
Kilitch Drugs' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
Based on the latest financial disclosure, Kilitch Drugs Limited has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The short ratio for all India stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
All Next | Launch Module |
Kilitch Fundamentals
Return On Equity | 0.0832 | ||||
Return On Asset | 0.0566 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 4.78 B | ||||
Shares Outstanding | 16.08 M | ||||
Shares Owned By Insiders | 74.84 % | ||||
Price To Book | 2.68 X | ||||
Price To Sales | 3.60 X | ||||
Revenue | 1.54 B | ||||
Gross Profit | 641.83 M | ||||
EBITDA | 286.33 M | ||||
Net Income | 193.54 M | ||||
Cash And Equivalents | 1.34 M | ||||
Total Debt | 316.46 M | ||||
Book Value Per Share | 109.62 X | ||||
Cash Flow From Operations | (56.69 M) | ||||
Earnings Per Share | 10.27 X | ||||
Target Price | 466.0 | ||||
Number Of Employees | 168 | ||||
Beta | 0.28 | ||||
Market Capitalization | 5.45 B | ||||
Total Asset | 2.4 B | ||||
Retained Earnings | 842.33 M | ||||
Working Capital | 817.77 M | ||||
Net Asset | 2.4 B |
About Kilitch Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kilitch Drugs Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kilitch Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kilitch Drugs Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kilitch Stock
Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.